The genetic basis of thoracic aortic disease: The future of aneurysm classification?

Davis, 1993, Smooth muscle cell to elastic lamina connections in developing mouse aorta: Role in aortic medial organization, Lab Invest, 68, 89 D'Arrigo, 1998, TGF-β1 binding protein-like modules of fibrillin-1 and-2 mediate integrin-dependent cell adhesion, Connect Tissue Res, 37, 29, 10.3109/03008209809028898 Godwin, 2019, The role of fibrillin and microfibril binding proteins in elastin and elastic fibre assembly, Matrix Biol, 84, 17, 10.1016/j.matbio.2019.06.006 Lakatta, 2009, Arterial Aging and Subclinical Arterial Disease are Fundamentally Intertwined at Macroscopic and Molecular Levels, Med Clin North Am, 93, 583, 10.1016/j.mcna.2009.02.008 Lacolley, 2009, Genetics and pathophysiology of arterial stiffness, Cardiovasc Res, 81, 637, 10.1093/cvr/cvn353 Reusch, 1996, Mechanical strain increases smooth muscle and decreases nonmuscle myosin expression in rat vascular smooth muscle cells, Circ Res, 79, 1046, 10.1161/01.RES.79.5.1046 Safar, 2010, Arterial aging-hemodynamic changes and therapeutic options, Nat Rev Cardiol, 7, 442, 10.1038/nrcardio.2010.96 Dietz, 1991, Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene, Nature, 352, 337, 10.1038/352337a0 Ramirez, 2003, Cell signaling events: A view from the matrix, Matrix Biol, 22, 101, 10.1016/S0945-053X(03)00002-7 Phillippi, 2011, Biomechanics and Pathobiology of Aortic Aneurysms Faivre, 2007, Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: An international study, Am J Hum Genet, 81, 454, 10.1086/520125 Turner, 2009, Detection of 53 FBN1 mutations (41 novel and 12 recurrent) and genotype - Phenotype correlations in 113 unrelated probands referred with marfan syndrome, or a related fibrillinopathy, Am J Med Genet Part A, 149, 161, 10.1002/ajmg.a.32593 Kielty, 2002, Fibrillin: From microfibril assembly to biomechanical function, Philos Trans R Soc B Biol Sci, 357, 207, 10.1098/rstb.2001.1029 Judge, 2004, Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome, J Clin Invest, 114, 172, 10.1172/JCI200420641 Neptune, 2003, Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome, Nat Genet, 33, 407, 10.1038/ng1116 Brooke, 2008, Angiotensin II blockade and aortic-root dilation in marfan's syndrome, N Engl J Med, 358, 2787, 10.1056/NEJMoa0706585 Sandor, 2015, A randomized, double blind pilot study to assess the effects of losartan vs. atenolol on the biophysical properties of the aorta in patients with Marfan and Loeys-Dietz syndromes, Int J Cardiol, 179, 470, 10.1016/j.ijcard.2014.11.082 Forteza, 2016, Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: A randomized clinical trial, Eur Heart J, 37, 978, 10.1093/eurheartj/ehv575 Loeys, 2006, Aneurysm syndromes caused by mutation in TGF-B receptor, N Engl J Med, 355, 788, 10.1056/NEJMoa055695 Loeys, 2005, A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2, Nat Genet, 37, 275, 10.1038/ng1511 Goudie, 2011, Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1, Nat Genet, 43, 365, 10.1038/ng.780 Van De Laar, 2011, Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis, Nat Genet, 43, 121, 10.1038/ng.744 Boileau, 2012, TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome, Nat Genet, 44, 916, 10.1038/ng.2348 Maleszewski, 2009, Histopathologic findings in ascending aortas from individuals with Loeys-Dietz Syndrome (LDS), Am J Surg Pathol, 33, 194, 10.1097/PAS.0b013e31817f3661 Franken, 2013, Circulating transforming growth factor-β as a prognostic biomarker in Marfan syndrome, Int J Cardiol, 168, 2441, 10.1016/j.ijcard.2013.03.033 Franken, 2015, The revised role of TGF-β in aortic aneurysms in Marfan syndrome, Neth Heart J, 23, 116, 10.1007/s12471-014-0622-0 Beighton, 1998, Ehlers-danlos syndromes: Revised nosology, Villefranche, 1997, Am J Med Genet, 77, 31, 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O Pepin, 2000, Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type, N Engl J Med, 324, 673, 10.1056/NEJM200003093421001 Narcisi, 1994, A family with ehlers - danlos syndrome type III/articular hypermobility syndrome has a glycine 637 to serine substitution in type III collagen, Hum Mol Genet, 3, 1617, 10.1093/hmg/3.9.1617 Pope, 1996, COL3A1 mutations cause variable clinical phenotypes including acrogeria and vascular rupture, Br J Dermatol, 135, 163, 10.1111/j.1365-2133.1996.tb01143.x Elsheikh, 2001, Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome, Clin Endocrinol, 54, 69, 10.1046/j.1365-2265.2001.01154.x Coucke, 2006, Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome, Nat Genet, 38, 452, 10.1038/ng1764 Purnell, 2005, Giant aneurysms of the sinuses of Valsalva and aortic regurgitation in a patient with Noonan's syndrome, Eur J Cardio-thoracic Surg., 28, 346, 10.1016/j.ejcts.2005.05.004 Friedman, 2002, Cardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task Force, Genet Med, 4, 105, 10.1097/00125817-200205000-00002 Siu, 2010, Bicuspid Aortic Valve Disease, J Am Coll Cardiol, 55, 2789, 10.1016/j.jacc.2009.12.068 El-Hamamsy, 2009, A measured approach to managing the aortic root in patients with bicuspid aortic valve disease, Curr Cardiol Rep, 11, 94, 10.1007/s11886-009-0015-y McKellar, 2007, Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms, J Thorac Cardiovasc Surg, 134, 290, 10.1016/j.jtcvs.2007.02.041 Callewaert, 2011, New insights into the pathogenesis of autosomal-dominant cutis laxa with report of five ELN mutations, Hum Mutat, 32, 445, 10.1002/humu.21462 Cripe, 2004, Bicuspid aortic valve is heritable, J Am Coll Cardiol, 44, 138, 10.1016/j.jacc.2004.03.050 Bravo-Jaimes, 2020, Genetics in bicuspid aortic valve disease: Where are we?, Prog Cardiovasc Dis, 63, 398, 10.1016/j.pcad.2020.06.005 Keane, 2000, Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions, Circulation, 102, 2 Erbel, 2014, ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European, Eur Heart J, 35, 2873, 10.1093/eurheartj/ehu281 Albornoz, 2006, Familial Thoracic Aortic Aneurysms and Dissections-Incidence, Modes of Inheritance, and Phenotypic Patterns, Ann Thorac Surg, 82, 1400, 10.1016/j.athoracsur.2006.04.098 Nicod, 1989, Familial aortic dissecting aneurysm, J Am Coll Cardiol, 13, 811, 10.1016/0735-1097(89)90221-0 Milewicz, 2008, Genetic Basis of Thoracic Aortic Aneurysms and Dissections: Focus on Smooth Muscle Cell Contractile Dysfunction, Annu Rev Genomics Hum Genet, 9, 283, 10.1146/annurev.genom.8.080706.092303 Fisher, 2010, Vascular smooth muscle phenotypic diversity and function, Physiol Genomics, 42, 169, 10.1152/physiolgenomics.00111.2010 Milewicz, 2017, Altered smooth muscle cell force generation as a driver of thoracic aortic aneurysms and dissections, Arterioscler Thromb Vasc Biol, 37, 26, 10.1161/ATVBAHA.116.303229 Guo, 2007, Mutations in smooth muscle α-actin (ACTA2) lead to thoracic aortic aneurysms and dissections, Nat Genet, 39, 1488, 10.1038/ng.2007.6 Guo, 2009, Mutations in Smooth Muscle Alpha-Actin (ACTA2) Cause Coronary Artery Disease, Stroke, and Moyamoya Disease, Along with Thoracic Aortic Disease, Am J Hum Genet, 84, 617, 10.1016/j.ajhg.2009.04.007 Zhu, 2006, Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus, Nat Genet, 38, 343, 10.1038/ng1721 Pannu, 2007, MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II, Hum Mol Genet, 16, 2453, 10.1093/hmg/ddm201 Wang, 2011, Mutations in Myosin Light Chain Kinase Cause Familial Aortic Dissections, Am J Hum Genet, 87, 701, 10.1016/j.ajhg.2010.10.006 Guo, 2013, Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections, Am J Hum Genet, 93, 398, 10.1016/j.ajhg.2013.06.019 Pfeifer, 1998, Defective smooth muscle regulation in cGMP kinase I-deficient mice, EMBO J, 17, 3045, 10.1093/emboj/17.11.3045 Blanton, 2013, Mutation of the protein kinase I alpha leucine zipper domain produces hypertension and progressive left ventricular hypertrophy: A novel mouse model of age-dependent hypertensive heart disease, Journals Gerontol - Ser A Biol Sci Med Sci., 68, 1351, 10.1093/gerona/glt042 Lemaire, 2011, Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1, Nat Genet, 43, 996, 10.1038/ng.934 Kuang, 2011, Recurrent chromosome 16p13.1 duplications are a risk factor for aortic dissections, PLoS Genet, 7, 10.1371/journal.pgen.1002118 Guo, 2017, Heritable Thoracic Aortic Disease Genes in Sporadic Aortic Dissection, J Am Coll Cardiol, 70, 2728, 10.1016/j.jacc.2017.09.1094 Kwartler, 2018, Variants of Unknown Significance in Genes Associated with Heritable Thoracic Aortic Disease Can Be Low Penetrant “Risk Variants, Am J Hum Genet, 103, 138, 10.1016/j.ajhg.2018.05.012 Richards, 2015, Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med, 17, 405, 10.1038/gim.2015.30 Renard, 2018, Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection, J Am Coll Cardiol, 72, 605, 10.1016/j.jacc.2018.04.089 Chong, 2015, The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities, Am J Hum Genet, 97, 199, 10.1016/j.ajhg.2015.06.009 Strande, 2017, Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome Resource, Am J Hum Genet, 100, 895, 10.1016/j.ajhg.2017.04.015 Salmasi, 2022, Determining the genetic contribution in patients with non-syndromic ascending thoracic aortic aneurysms: Correlation with findings from computational pathology, Int J Cardiol, 366, 1, 10.1016/j.ijcard.2022.07.010 Dean, 2018, Marfan syndrome and related disorders, 157 Dasouki, 2007, Compound heterozygous mutations in fibulin-4 causing neonatal lethal pulmonary artery occlusion, aortic aneurysm, arachnodactyly, and mild cutis laxa, Am J Med Genet Part A, 143, 2635, 10.1002/ajmg.a.31980 Curran, 1993, The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis, Cell, 73, 159, 10.1016/0092-8674(93)90168-P Superti-Furga, 1988, Ehlers-Danlos syndrome type IV: A multi-exon deletion in one of the two COL3A1 alleles affecting structure, stability, and processing of type III procollagen, J Biol Chem, 263, 6226, 10.1016/S0021-9258(18)68776-9 Isotalo, 1999, Aortic dissection: A rare complication of osteogenesis imperfecta, Can J Cardiol, 15, 1139 Wenstrup, 1989, Ehlers-Danlos syndrome type VI: Clinical manifestations of collagen lysyl hydroxylase deficiency, J Pediatr, 115, 405, 10.1016/S0022-3476(89)80839-X Mizuguchi, 2004, Heterozygous TGFBR2 mutations in Marfan syndrome, Nat Genet, 36 Doyle, 2012, Mutations in the TGF-β repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm, Nat Genet, 44, 1249, 10.1038/ng.2421 Iwasaki, 2009, Coronary artery dilatation in LEOPARD syndrome. A child case and literature review, Congenit Heart Dis, 4, 38, 10.1111/j.1747-0803.2008.00243.x Mäki, 2002, Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice, Circulation, 106, 2503, 10.1161/01.CIR.0000038109.84500.1E Hillebrand, 2014, Total serum transforming growth factor-β1 is elevated in the entire spectrum of genetic aortic syndromes, Clin Cardiol, 37, 672, 10.1002/clc.22320